Pembrolizumab + GVD with ctdna-guided consolidation for relapsed/refractory classic Hodgkin lymphoma: A multicenter phase 2 Study of the University of California hematologic malignancies consortiumMichael P. Randall, Michael A. Spinner, Chiung‐Yu Huang et al.|Blood|2025Cited by 1